Seattle Genetics (SGEN) Tops Q3 EPS by 6c

Seattle Genetics (NASDAQ: SGEN) reported Q3 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $106.3 million versus the consensus estimate of $101.74 million.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Change in Nonfarm Payrolls (Sep) 29K vs 90K Expected, Unemployment Rate 4.2%
• Piper Sandler on Virtu Financial (VIRT): 'The most overlooked name in our coverage'